Please enable JS

ARTICLES & TESTIMONIALS

Biosimilar Confidence: Patient Perspectives on a New Medication Class – Seth Ginsberg

Jul 15/50SN Staff/ GHLF in the news

Imagine you’ve been living with rheumatoid arthritis for more than ten years.

READ MORE

Victory in Missouri

Jun 09/50SN Staff/ Victories

At its core, HB 1366 boils down to two words: Trust and transparency.

READ MORE

GHLF Supports OH HB 505

Apr 19/50SN Staff/ Letters and Testimony

HB 505 takes positive steps toward updating Ohio law to cover biologics and biosimilars in a
way that protects patients. As you know, unlike traditional chemical drugs, biologics are unique,
complex structures made from living cells that are not easily replicated. A small change or
difference in the biosimilar or biologic manufacturing process has the potential to adversely
impact the patient.

READ MORE

Victory in Oregon

Apr 08/50SN Staff/ Victories

Last year in March, 50-State Network advocate Anna Marie Meyer testified before the Oregon House of Representatives Committee on Health Care in opposition to HB 2026.

READ MORE

GHLF supports HI HB 254 HD2

Mar 24/50SN Staff/ Letters and Testimony

HB 254 HD 2 takes positive steps toward updating Hawaii law to cover biologics and biosimilars
in a way that protects patients. As you know, unlike traditional chemical drugs, biologics are
unique, complex structures made from living cells that are not easily replicated. A small change
or difference in the biosimilar or biologic manufacturing process has the potential to adversely
impact the patient.

READ MORE